Comprehensive Snapshot of Dual Energy X-ray Absorptiometry Market Research Report, Including Regional and Country Analysis in Brief.
Industry: Healthcare
Delivery Timelines: Please Contact Sales
Published Date: May-2025
Format: PPT*, PDF, EXCEL
Number of Pages: 198
ID: PMRREP35336
The global dual-energy X-ray absorptiometry market is anticipated to reach a value of US$686.3 Mn in 2025 and witness a CAGR of 7.7% and value at US$1,153.5 Mn by 2032. Dual-energy X-ray absorptiometry (DEXA) is widely regarded as the most advanced and extensively validated technique for measuring bone mineral density (BMD), as recognized by the World Health Organization in its osteoporosis prevention guidelines. This technology plays a crucial role in diagnosing osteoporosis, predicting fracture risks, and tracking treatment efficacy. DEXA is also referred as bone densitometry, has become the gold standard for BMD assessment due to its accuracy and consistency. The two different X-ray energy levels, precisely delivers results regardless of soft tissue variations while exposing patients to minimal radiation.
The technique enables axial, peripheral, and whole-body scans, offering insights into bone density, fat distribution, and lean mass composition. Additionally, its high precision allows for the detection of subtle changes in bone mineral content across multiple anatomical sites, making it an essential tool for bone health evaluation and disease management.
Key Industry Highlights:
|
Global Market Attribute |
Key Insights |
|
Dual Energy X-ray Absorptiometry Market Size (2025E) |
US$ 686.3 Mn |
|
Market Value Forecast (2032F) |
US$ 1,153.5 Mn |
|
Projected Growth (CAGR 2025 to 2032) |
7.7% |
|
Historical Market Growth (CAGR 2019 to 2024) |
6.9% |
The global dual-energy X-ray absorptiometry market is experiencing significant growth due to the increasing prevalence of osteoporosis and other bone-related conditions. As population ages and sedentary lifestyles become more common, the demand for early diagnosis and monitoring of osteoporosis has risen. DEXA's precision in assessing bone mineral density enables early detection, facilitating timely treatment to minimize fracture risks.
Additionally, growing awareness and a proactive approach to bone health management are driving the adoption of DEXA systems worldwide. Continuous technological advancements in DEXA have further contributed to market expansion by improving accuracy, efficiency, and safety, making these systems more appealing to both patients and healthcare professionals. Furthermore, rising healthcare expenditures in both developed and emerging economies are enabling medical facilities to invest in advanced diagnostic technologies like DEXA systems.
A key restraint in the Dual Energy X-ray Absorptiometry (DEXA) market is the physical limitation and patient compliance required during the scanning procedure. Patients must remain still while lying flat on their backs for up to 10 minutes, which can be challenging for individuals with mobility issues, severe arthritis, respiratory difficulties, or other health conditions that limit their ability to lie supine for extended periods. This restricts DEXA scanning in certain patient populations, particularly among the elderly or those with chronic illnesses.
Additionally, most standard DEXA machines have a weight limit of around 300 pounds. Patients exceeding this threshold require alternative bone mineral density (BMD) testing methods, as the equipment cannot safely or accurately accommodate them. Since weight limits vary by model, healthcare facilities must verify device specifications before scheduling patients. These physical and equipment constraints reduce the pool of eligible patients and may impact the overall adoption rate of DEXA technology.
DEXA is densely used for body composition analysis in sports science, fitness facilities, and wellness initiatives in addition to its conventional clinical usage for osteoporosis detection. Its ability to accurately measure fat mass, lean tissue, and visceral fat makes it a valuable tool for athletes, trainers, and health-conscious individuals aiming to optimize performance and track health improvements. This trend opens new, non-clinical revenue streams for DEXA manufacturers and service providers. With rising interest in personalized fitness and preventive healthcare, especially in urban and affluent demographics, the demand for precise body composition assessment tools is growing. This shift is supported by partnerships between healthcare providers and fitness organizations, as well as the integration of DEXA services in corporate wellness programs. As awareness spreads about the value of body composition data beyond simple weight metrics, the DEXA market stands to benefit from broader, lifestyle-focused applications.
Axial/Central is the leading technology segment in the global market and is projected to hold 61.5% of the market share in 2025. Axial or central DEXA remains the dominant technology in the dual-energy X-ray absorptiometry market due to its superior accuracy in measuring bone mineral density (BMD) at critical skeletal sites such as the spine and hip. These areas are particularly important in osteoporosis diagnosis and fracture risk assessment. According to the clinical studies, axial DEXA provides significantly higher precision and reproducibility compared to peripheral systems, making it the gold standard for osteoporosis screening and treatment monitoring.
Additionally, its role extends beyond bone health assessment, with applications in sports medicine and obesity management. Axial DEXA is widely used for detailed body composition analysis, including measurements of body fat and lean mass, which are essential for evaluating overall health and fitness. With the increasing global burden of osteoporosis and growing emphasis on preventive healthcare, the demand for axial DEXA systems continues to rise across hospitals, diagnostic centers, and research institutions.
Osteoporosis remains the dominant segment in the dual-energy X-ray absorptiometry market due to its rising prevalence, particularly among the aging population. According to the International Osteoporosis Foundation, approximately 200 million women worldwide suffer from osteoporosis, significantly increasing their risk of fractures. The condition is a major public health concern, with hip fractures being among the most severe complications.
A study published by the National Center for Biotechnology Information (NCBI) projects that by 2050, the global incidence of hip fractures will surge by 310% in men and 240% in women. Additionally, the International Osteoporosis Foundation estimates that, worldwide, an osteoporotic fracture occurs every three seconds. With growing awareness of bone health and the importance of early diagnosis, routine DEXA screenings are becoming more common. Government initiatives and healthcare programs promoting osteoporosis screening and management are further propelling the growth, emphasizing the need for advanced diagnostic technologies.
The North American market is witnessing significant growth, driven by the rising prevalence of osteoporosis, particularly among the aging population. In the U.S., 10 million people are affected by osteoporosis, with 12.6% of adults over 50 diagnosed with the condition.
The prevalence increases with age, reaching 8.4% among those aged 50-64 and 17.7% of individuals over 65. Women are disproportionately affected, with a 13.1% prevalence between 50-64 years and 27.1% in those over 65, compared to 3.3% and 5.7% in men, respectively. With the increasing burden of osteoporosis, DEXA adoption is accelerating for early diagnosis and treatment monitoring. Additionally, increased health awareness, routine screening programs, and technological advancements in DEXA imaging are further fueling market expansion. As osteoporosis remains underdiagnosed, greater emphasis on preventive healthcare and bone health assessments is expected to drive continued demand for DEXA systems across North America.
The growing prevalence of osteoporosis across Europe is driving increased demand for DEXA systems, particularly in countries like the UK, Germany, and France. In the UK alone, 21.9% of women and 6.7% of men over 50 are diagnosed with osteoporosis, according to the International Osteoporosis Foundation, highlighting the urgent need for early detection and intervention. Similar trends are observed across aging European populations, where osteoporosis-related fractures pose a significant healthcare burden.
Governments and healthcare organizations are actively promoting bone health awareness campaigns and routine osteoporosis screenings, further fueling DEXA adoption. Additionally, technological advancements in DEXA imaging, including automated analysis, improved precision, and lower radiation exposure, are making these systems more accessible across hospitals, clinics, and diagnostic centers. As preventive healthcare initiatives gain momentum in Europe, the DEXA market is poised for substantial growth, ensuring better osteoporosis management and reducing fracture risks.
Asia Pacific is poised for rapid expansion, making it the fast-growing region during the forecast period. This growth is driven by increasing healthcare awareness and expanding healthcare infrastructure investments. Countries like India, China, and Japan are at the forefront of medical technology advancements, pharmaceutical innovation, and healthcare service enhancements, fueling demand for DEXA systems.
Additionally, osteoporosis cases are surging due to aging demographics, sedentary lifestyles, and dietary shifts, creating a greater need for early bone health assessments. Governments across Asia Pacific are prioritizing preventive healthcare, implementing osteoporosis screening programs, and encouraging technological adoption in diagnostics. With growing medical tourism, increasing healthcare expenditures, and rising awareness about bone-related disorders, DEXA adoption is set to surge, establishing the Asia Pacific as a key driver of the global market’s rising compound annual growth rate (CAGR).
The Middle East & Africa (MEA) dual-energy X-ray absorptiometry market is poised for growth, driven by shifting demographics and a rising aging population. In Saudi Arabia, for example, the number of individuals aged 60 and above is projected to increase fivefold, from 2 million (5.9% of the total population) in 2020 to 10.5 million by 2050. Since older adults are more vulnerable to osteoporosis, this demographic shift is expected to drive the demand for DEXA scans for early diagnosis and treatment monitoring. Additionally, increasing healthcare investments and awareness of bone health management will further support market expansion.
The Latin American DEXA market is experiencing steady growth. Countries such as Brazil, Mexico, and Argentina are seeing a surge in osteoporosis-related fractures, pushing healthcare providers to invest in early detection and prevention strategies. The economic burden of osteoporosis-related complications has prompted governments and private healthcare institutions to implement routine screening programs, making DEXA scans more accessible.
Moreover, rising healthcare expenditure, along with improved medical insurance coverage, is facilitating DEXA adoption in hospitals and diagnostic centers. In addition, growing awareness of bone health and preventive care, especially among postmenopausal women, is fueling demand for DEXA technology. As healthcare infrastructure expands and diagnostic capabilities improve, the LATAM DEXA market is expected to witness sustained growth, ensuring better osteoporosis management and fracture prevention across the region.
The dual-energy X-ray absorptiometry market is primarily led by GE Healthcare, Fujifilm, OSTEOSYS, and Diagnostic Medical Systems (DMS), collectively holding more than 50% of the market share. These key players focus on product innovation and engage in strategic collaborations to strengthen their market presence. Partnerships with hospitals, research centers, and healthcare institutions are crucial for expanding its reach, ensuring compliance with regulatory standards, and advancing bone densitometry technology.
A major area of focus for these companies is enhancing imaging accuracy while integrating advanced software solutions. Additionally, the increasing adoption of digital health technologies and telemedicine is prompting manufacturers to develop connected DEXA systems, facilitating remote diagnostics and seamless data exchange between healthcare providers.
|
Report Attribute |
Details |
|
Historical Data/Actuals |
2019 - 2024 |
|
Forecast Period |
2025 - 2032 |
|
Market Analysis Units |
Value: US$ Mn, Volume: As applicable |
|
Geographical Coverage |
|
|
Segmental Coverage |
|
|
Competitive Analysis |
|
|
Report Highlights |
|
|
Customization and Pricing |
Available upon request |
By Technology
By Application
By End-user
By Region
To know more about delivery timeline for this report Contact Sales
The global market is estimated to increase from US$ 686.3 million in 2025 to US$ 1,153.5 million in 2032.
Increased sports injuries, precision in body composition analysis, expanding clinical applications, and government initiatives drive market growth.
The market is projected to record a CAGR of 7.7% during the forecast period from 2025 to 2032.
GE Healthcare, Hologic, Aurora Spine, DMS Group, Scintica Instrumentation, Inc. and Others.
Growing osteoporosis cases, technological advancements, AI integration, and portable DXA devices drive market expansion opportunities.
